Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653964 · ClinicalTrials.gov registry record · NA
Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT01653964: Completed NA study, sponsored by Mayo Clinic.
NCT01653964 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01653964, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The primary objective of this work is to determine if half-dose Molecular Breast Imaging (MBI) performed with 4 mCi Tc-99m sestamibi with or without Wide Beam Reconstruction applied can achieve image quality and diagnostic accuracy non-inferior to that of standard MBI performed with 8 millicurie (mCi) Tc-99m sestamibi.
Interventions
- DIAGNOSTIC_TEST Molecular breast imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653964
The ClinicalTrials.gov registry entry for NCT01653964 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular breast imaging is the first listed.
NCT01653964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01653964 about?
NCT01653964 is a clinical study titled "Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing". The primary objective of this work is to determine if half-dose Molecular Breast Imaging (MBI) performed with 4 mCi Tc-99m sestamibi with or without Wide Beam Reconstruction applied can achieve image quality and diagnostic accuracy non-inferior to that of standard MBI performed with 8 millicurie (mC...
What is the current status of trial NCT01653964?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2012-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01653964?
The interventions under investigation include: Molecular breast imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01653964?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.